论文部分内容阅读
在今天的资本市场中,股价翻倍并非难事,可业绩与股价有同等爆发的企业却寥寥无几。在2014年,亚宝药业(600351.SH)给投资者呈现了每股收益44%的同比增长,去除非经常性损益后,其每股收益同比增长更高达94.17%。即使每年只以44%的速度增长,如今借助牛市东风骤起的股价也只需要两个这样的连续增长就能获得有效支撑。到底是什么让亚宝药业获得了新的增
In today’s capital markets, a doubling of share prices is not difficult, and there are only a handful of companies that have the same outburst of performance and share prices. In 2014, Yabao Pharmaceuticals (600351.SH) presented investors with a year-on-year increase of 44% in earnings per share. After deducting non-recurring gains and losses, its earnings per share increased by as much as 94.17% from the same period last year. Even with an annual increase of only 44%, the stock price that is now booming by the bull market is effectively supported by only two such consecutive increases. In the end what makes Ya Bao Pharmaceutical has gained new growth